tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

HUTCHMED Releases 2024 Annual Report and Announces Hybrid AGM
Company AnnouncementsHUTCHMED Releases 2024 Annual Report and Announces Hybrid AGM
10d ago
HUTCHMED Announces Approval of Key Resolution at Extraordinary General Meeting
PremiumCompany Announcements
HUTCHMED Announces Approval of Key Resolution at Extraordinary General Meeting
17d ago
Hutchmed says NDA for Tazverik granted conditional approval in China
PremiumThe Fly
Hutchmed says NDA for Tazverik granted conditional approval in China
27d ago
HCM
HUTCHMED Secures NMPA Approval for TAZVERIK® in China
PremiumCompany Announcements
HUTCHMED Secures NMPA Approval for TAZVERIK® in China
27d ago
HUTCHMED’s Strong Financial Performance and Strategic Growth Drive Buy Rating
PremiumRatings
HUTCHMED’s Strong Financial Performance and Strategic Growth Drive Buy Rating
27d ago
HCM
HUTCHMED Announces Board Changes Following Director Retirements
PremiumCompany AnnouncementsHUTCHMED Announces Board Changes Following Director Retirements
28d ago
HUTCHMED’s Savolitinib Shows Promising Results in Lung Cancer Trials
Premium
Company Announcements
HUTCHMED’s Savolitinib Shows Promising Results in Lung Cancer Trials
28d ago
HUTCHMED Files Annual Report with SEC, Affirming Market Position
Premium
Company Announcements
HUTCHMED Files Annual Report with SEC, Affirming Market Position
29d ago
Hutchmed sees FY25 Oncology/Immunology revenue $350M-$450M
PremiumThe Fly
Hutchmed sees FY25 Oncology/Immunology revenue $350M-$450M
29d ago
HCM
Hutchmed reports FY24 EPS 22c vs. 59c last year
PremiumThe Fly
Hutchmed reports FY24 EPS 22c vs. 59c last year
29d ago
HCM
HUTCHMED Achieves Profitability with Strong Oncology Growth and Strategic Developments
PremiumCompany Announcements
HUTCHMED Achieves Profitability with Strong Oncology Growth and Strategic Developments
29d ago
Hutchmed/Innovent update on Phase 2/3 study of Fruquintinib+Sintilimab
PremiumThe Fly
Hutchmed/Innovent update on Phase 2/3 study of Fruquintinib+Sintilimab
29d ago
HCM
HUTCHMED and Innovent’s Combination Therapy Shows Promise in Advanced Renal Cell Carcinoma
PremiumCompany AnnouncementsHUTCHMED and Innovent’s Combination Therapy Shows Promise in Advanced Renal Cell Carcinoma
29d ago
HUTCHMED Announces Vesting of LTIP Awards
Premium
Company Announcements
HUTCHMED Announces Vesting of LTIP Awards
1M ago
HUTCHMED Adopts 2025 Long Term Incentive Plan to Drive Growth
Premium
Company Announcements
HUTCHMED Adopts 2025 Long Term Incentive Plan to Drive Growth
1M ago
HUTCHMED Announces EGM for Strategic Disposal Approval
PremiumCompany Announcements
HUTCHMED Announces EGM for Strategic Disposal Approval
1M ago
Hutchmed completes enrollment of fanregratinib trial
PremiumThe Fly
Hutchmed completes enrollment of fanregratinib trial
1M ago
HCM
HUTCHMED Appoints Alvin Wong as Independent Non-executive Director
PremiumCompany Announcements
HUTCHMED Appoints Alvin Wong as Independent Non-executive Director
1M ago
HUTCHMED Announces Major Equity Disposal in SHPL
PremiumCompany Announcements
HUTCHMED Announces Major Equity Disposal in SHPL
2M ago
HUTCHMED Updates on Disposal of Shanghai Hutchison Pharmaceuticals Stake
PremiumCompany AnnouncementsHUTCHMED Updates on Disposal of Shanghai Hutchison Pharmaceuticals Stake
2M ago
HUTCHMED to Unveil 2024 Financial Results and Host Webcast
Premium
Company Announcements
HUTCHMED to Unveil 2024 Financial Results and Host Webcast
2M ago
Hutchmed price target raised to $27 from $26 at BofA
Premium
The Fly
Hutchmed price target raised to $27 from $26 at BofA
2M ago
HCM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >